Long COVID prevalence and risk factors in adults residing in middle- and high-income countries: secondary analysis of the multinational Anti-Coronavirus Therapies (ACT) trials
Symptoms of long COVID are reported in a quarter of cases of symptomatic COVID-19 in this study and were significantly more prevalent in participants from countries with lower income status and in patients of Arab/North African ethnicity. Research to further assess the health burden posed by long COVID in low- and middle-income countries is urgently needed.
Authors
- Lucas E. Hermans (ORCID: https://orcid.org/0000-0002-8741-5852)
- John W. Eikelboom (ORCID: https://orcid.org/0000-0003-4126-1285)
- Sean Wasserman (ORCID: https://orcid.org/0000-0002-3508-6719)
- Lizhen Xu (ORCID: https://orcid.org/0000-0003-4921-7238)
Institutions
- St George's, University of London (GB)
- Groote Schuur Hospital (ZA)
- Population Health Research Institute (CA)
- Wellcome Centre for Infectious Diseases Research in Africa (ZA)
- McMaster University (CA)
Publication Details
- Journal
- BMJ Global Health
- Published
- 2025-04-01
- DOI
- https://doi.org/10.1136/bmjgh-2024-017126
- Citations
- 8
- Primary Topic
- Long-Term Effects of COVID-19
- Type
- article
- Field-Weighted Citation Impact
- 11.11
Funders
- Wellcome Trust